Results 71 to 80 of about 32,181 (207)

Intranasal glucocorticosteroids for the complex treatment of patients with chronic diseases of the nose and paranasal sinuses

Медицинский совет, 2020
Intriduction. Chronic rhinitis and rhinosinusitis noticeably deteriorate the patients’ quality of life and lead to the accompanying upper airway pathology development.
P. A. Kochetkov, V. A. Svistushkin, E. S. Shchennikova   +2 more
doaj   +1 more source

Novel drug-delivery systems for patients with chronic rhinosinusitis

, 2012
Silviu AlbuDepartment of Otolaryngology, University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, RomaniaAbstract: Chronic rhinosinusitis, one of the most common chronic medical complaints in the United States, seems to be increasing in incidence ...
Albu S
core  

Immunomodulators in chronic rhinosinusitis

World Journal of Otorhinolaryngology - Head and Neck Surgery, 2018
ObjectiveTo provide new insight into how chronic rhinosinusitis (CRS) is conceptualized and treated with a focus on immunomodulator therapy.Data sourcesPubmed, Medline, and Embase.MethodsA current review of the evidence is provided for immunomodulators investigated for treatment of CRS with nasal polyps (CRSwNP).ResultsBiologic therapies targeting IgE,
Philippe Lavigne, Stella E. Lee
openaire   +3 more sources

Update on the management of chronic rhinosinusitis

, 2013
Rachel B Cain, Devyani LalDepartment of Otorhinolaryngology, Mayo Clinic, Phoenix, AZ, USAAbstract: Chronic rhinosinusitis (CRS) is a common disorder characterized by mucosal inflammation of the nose and paranasal sinuses with sinonasal symptoms ...
Lal D, Cain RB
core  

Indications, Efficacy, and Safety of Intranasal Corticosteriods in Rhinosinusitis

World Allergy Organization Journal, 2012
Rhinosinusitis is a significant health problem, causing significant morbidity and resulting in considerable financial cost. Some patients suffer persistent or recurrent symptoms despite receiving optimal medical and surgical treatment. Rhinosinusitis can
Paul C Potter, MD, FCP(SA), FAAAAI, FACAAI, Ruby Pawankar, MD, PhD   +1 more
doaj   +1 more source

Prevention of chronic rhinosinusitis

Rhinology journal, 2018
Prevention of chronicity of disease and minimising its impact with individualized treatment is a fundamental tenet of precision medicine. A review of the literature has been undertaken to explore how this may apply to chronic rhinosinusitis (CRS). Prevention may be thought of across 3 main domains.
Hopkins, Claire, Surda, Pavol, Bast, Florian, Hettige, Roland, Walker, Abigail, Hellings, Peter W.   +5 more
openaire   +3 more sources

Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review

Brazilian Journal of Otorhinolaryngology
Introduction: Chronic rhinosinusitis with nasal polyps is a multifactorial disease with a complex pathophysiology involving multiple genetic and environmental factors.
Vanessa Ramos Pires Dinarte, Anemari Ramos Dinarte dos Santos, Luiza Ferreira de Araújo, Mariah Guieiro Alves dos Reis, Edwin Tamashiro, Fabiana Cardoso Pereira Valera, Wilson Araújo da Silva Júnior, Wilma Terezinha Anselmo-Lima   +7 more
doaj   +1 more source

Breath volatolomics for diagnosing chronic rhinosinusitis

, 2018
Yoav Y Broza,1,* Itzhak Braverman,2,* Hossam Haick1 1The Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion – Israel Institute of Technology, Haifa, Israel; 2The Otolaryngology – Head & Neck Surgery ...
Broza YY, Haick H, Braverman I
core  

Precision medicine in chronic rhinosinusitis

, 2023
Βιβλιογραφία : σ. 57 - 64Η χρόνια ρινοκολπίτιδα είναι μια επίμονη φλεγμονή του βλεννογόνου της ρινός και των παραρρινίων κόλπων πολυπαραγοντικής αιτιολογίας με γενετική, πε-ριβαλλοντική, βακτηριακή, και ανοσολογική συνεισφορά.
Spyridakis, Antonios, Σπυριδάκης, Αντώνιος   +1 more
core   +1 more source

Developing a core outcome set for chronic rhinosinusitis: a systematic review of outcomes utilised in the current literature

Trials, 2017
Background A core outcome set (COS) is an agreed standardised collection of outcomes that should be measured and reported by all trials for a specific clinical area, in this case chronic rhinosinusitis.
Archana Soni-Jaiswal, Raj Lakhani, Claire Hopkins   +2 more
doaj   +1 more source